empty
31.05.2022 12:48 PM
Prospective purchase of Gilead Sciences Inc (GILD) shares

Global disadvantages and risks:

Gilead Sciences shares were under the strongest pressure until mid-March of this year. The decrease in the impact of the coronavirus pandemic played a role here, which stimulated a wide demand for shares of pharmaceutical companies. But it still has problems, though not so critical. The company has a high level of debt of $ 26.208 billion as of March 31, 2022, to the amount of equity of $ 19.915 billion, which corresponds to 131.6%. But it should also be noted that the company's debt is well covered by operating cash flow of 40.5% and is offset by EBIT coverage of 11.3 times. It is expected that by the end of this year, revenue will decrease to $ 24.574 billion, and net income will decrease to $ 4.227 billion. It is assumed that earnings per share (EPS) at the end of 2022 will decrease to $ 3.436. According to 12 analysts, the possible range of EPS is from $ 3.030 to $ 4.500. Gilead Sciences had a large one-time loss of $ 4.3 billion, which affected the results of the last fiscal year. The price/profit ratio (P/E) is 18.1x, which is higher than the industry average, where the average value of the indicator is 15.5x, and the US market is 15.5x.

Positive:

The company is currently profitable. Profit is projected to grow by an average of 8.4% per year over the next 3 years. Gilead Sciences' margin improved. No events of concern have been detected, it has no negative equity. The company's shares were not diluted. The company has a projected profit growth of 8.4% above the savings rate of 1.9%. It is assumed that the return on capital over the next 3 years will increase by 28.6% against the industry average, which is 22.5%. Gilead Sciences' short-term assets of $ 12.6 billion exceed its short-term liabilities of $ 8.6 billion.

Gilead Sciences may resume trials of injectable lenacapavir for the treatment of HIV infection, which is a positive for the company's shares.

Distribution of 28 analyst recommendations on the company's shares: 15 to hold; 11 to buy; 2 to actively buy. The overall rating of recommendations for the company 2.5 is shifted towards buy. The company's shares are noticeably undervalued.

Key financial indicators:

The market capitalization is $ 81.96 billion.

Revenue for the last 12 months (TTM) was $ 27.472 billion.

Net profit for the last 12 months (TTM) $ 4.515 billion.

PEG 12 months (TTM) 0.54

P/E 12 months (TTM) 18.10

EPS 12 months (TTM) 3.58

Free Cash Flow (FCF) of $ 9.953 billion.

Dividend per share (%) 4.51

Dividend per share ($) 2.92

Ex-dividend date - 14.06.2022

The next dividend payment date is 27.07 - 01.08.2022.

Technical picture:

The security is trading above the support level of 64.00 on the daily chart, remaining in a three-month upward trend. The price is above the middle line of the Bollinger indicator. The MACD indicator is growing. The Relative Strength Index (RSI) is above the 50% level and is turning up.

Trading recommendation.

The stock is trading above the 50 and 100 daily moving averages. The price is above the support level of 64.00. The company's shares are slightly declining on the premarket by 0.203 to 64.78 from Monday's closing level of 64.80 (+0.51%).

Likely target levels:

The 1st target is 66.70 (short-term target) from yesterday's closing price of 64.80 (expected yield of 2.84%).

The 2nd goal is 68.85 (expected yield of 5.88%).

Conclusions:

We believe that the Gilead Sciences stock has a good potential for recovery growth. The paper can grow to the 3rd target mark in the period from 1 to 3 months.

This image is no longer relevant

Pati Gani,
Analytical expert of InstaForex
© 2007-2025
Select timeframe
5
min
15
min
30
min
1
hour
4
hours
1
day
1
week
Earn on cryptocurrency rate changes with InstaForex
Download MetaTrader 4 and open your first trade
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST

Recommended Stories

Update on US stock market on May 9. SP500 and NASDAQ trading higher

At the close of the last regular session, US stock indexes ended in the green. The S&P 500 rose by 0.58%, the Nasdaq 100 gained 1.07%, and the industrial

Jakub Novak 15:36 2025-05-09 UTC+2

S&P 500 Forecast for May 9, 2025

The U.S. stock market has overcome uncertainty and is set for growth towards new all-time highs. The price has settled above the indicator lines of the Balance Line

Laurie Bailey 05:15 2025-05-09 UTC+2

Update on US stock market on May 8. SP500 and NASDAQ grow after Fed's policy meeting

US benchmark stock indices closed the previous regular session with gains. The S&P 500 rose by 0.43%, the Nasdaq 100 added 0.27%, and the industrial Dow Jones climbed 0.70%. Futures

Jakub Novak 16:22 2025-05-08 UTC+2

Update on US stock market on May 7. Fed's policy decision on investors' radars

S&P500 Update on US market: pullback ahead of the Fed's policy meeting Snapshot of major US stock indexes on Tuesday: Dow -1%, NASDAQ -0.9%, S&P 500 -0.8%, S&P

Jozef Kovach 11:14 2025-05-07 UTC+2

Update on US stock market on May 6, 2025

S&P500 Overview on May 6 Snapshot of key US majo stock indices on Monday: * Dow: -0.2%, * NASDAQ: -0.7%, * S&P 500: -0.6% * S&P 500 closed at 5,650

Jozef Kovach 16:47 2025-05-06 UTC+2

US stock market still growing

S&P500 Update on US stock market: uptrend still going on Snapshot of major US indices on Friday: Dow +1.4% NASDAQ +1.5% S&P 500 +1.5% S&P 500 closed at 5,686, trading

Jozef Kovach 11:28 2025-05-05 UTC+2

US market: modest but positive move

S&P 500 Summary for May 2 The US market showed a modest but steady rise. On Friday, the main US indices closed in positive territory: the Dow Jones rose

Jozef Kovach 13:38 2025-05-02 UTC+2

US stock market on May 2: S&P 500 and Nasdaq still battling volatility

US stock indices ended the previous regular session higher. The S&P 500 rose 0.63%, while the Nasdaq 100 gained 0.52%. The Dow Jones Industrial Average edged up by 0.21%

Jakub Novak 13:33 2025-05-02 UTC+2

US market: GDP shrinks, but Wall Street climbs

S&P 500 Overview for May 1 GDP contracts, but US market climbs Key US indices on Friday: Dow +0.4%, NASDAQ -0.1%, S&P 500 +0.2%, S&P 500: 5,560, trading range: 5,150–5,800

Jozef Kovach 12:19 2025-05-01 UTC+2

Stock Market for April 30th: S&P 500 and NASDAQ Continue Clinging to Any Positive News

At the close of the previous regular session, U.S. stock indices finished in positive territory. The S&P 500 rose by 0.58%, and the Nasdaq 100 gained 0.55%. The Dow Jones

Jakub Novak 11:10 2025-04-30 UTC+2
Can't speak right now?
Ask your question in the chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.